Feb 28 (Reuters) - AstraZeneca Plc has sold its
stake in Moderna Inc for more than $1 billion after the
American biotechnology company's shares soared on the back of
its coronavirus vaccine breakthrough, The Times reported.
The report added that it was not clear when and over what
period AstraZeneca sold its full holding in Moderna.
(Reporting by Maria Ponnezhath in Bengaluru; editing by
Jonathan Oatis)